PhotoMedex Launches New Corporate Website.MONTGOMERYVILLE, Pa. -- PhotoMedex, Inc. (Nasdaq: PHMD), a provider of healthcare solutions, today announced the launch of its new corporate website. The completely redesigned site, which is located at PhotoMedex's current URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. of www.photomedex.com, contains new features such as site search functionality and improved navigation. PhotoMedex made the strategic decision to consolidate the corporate websites of both Procyte (www.procyte.com) and Surgical Laser Technologies (www.slti.com) under the PhotoMedex umbrella to offer doctors, patients and investors a clear, complete view of the company's offering in the areas of dermatology lasers, therapeutic skin, hair and wound care products and surgical products & services. "Over the past few years, PhotoMedex has greatly expanded its product offering. One of the challenges of growing at a fast pace is accurately presenting to the public who we are, what we do and what we have to offer," said Jeffrey O'Donnell, president and chief executive officer. "This new website accurately reflects our company image and provides clear information on our full line of products and services." ABOUT PHOTOMEDEX: PhotoMedex is engaged in the development of proprietary excimer laser A gas laser in which a very short electrical pulse excites a mixture containing a halogen such as fluorine and a rare gas such as argon or krypton. It produces a brief, intense pulse of ultraviolet light. and fiber optic systems and techniques directed toward dermatological applications, with FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. 510(k) clearances to market the XTRAC([R]) laser system for the treatment of psoriasis psoriasis (sôrī`əsĭs), occasionally acute but usually chronic and recurrent inflammation of the skin. The exact cause is unknown, but the disease appears to be an inherited, possibly autoimmune disorder that causes the , vitiligo vitiligo or leukoderma Skin disorder manifested by smooth, white spots on various parts of the body. Though the pigment-making cells of the skin, or melanocytes, are structurally intact, they have lost the ability to synthesize the pigment. , atopic dermatitis Atopic Dermatitis Definition Eczema is a general term used to describe a variety of conditions that cause an itchy, inflamed skin rash. Atopic dermatitis, a form of eczema, is a non-contagious disorder characterized by chronically inflamed skin and and leukoderma leukoderma /leu·ko·der·ma/ (-der´mah) an acquired condition with localized loss of pigmentation of the skin. leukoderma acquisi´tum centri´fugum halo nevus. . In addition, the Company provides contract medical procedures to hospitals, surgi-centers and doctors' offices, offering a wide range of products and services across multiple specialty areas, including dermatology, urology urology Medical specialty dealing with the urinary system and male reproductive organs. It traces its origin to medieval lithologists, itinerant healers who specialized in surgical removal of bladder stones. , gynecology, orthopedics, and other surgical specialties In all modern medical training programs, a surgeon must specialise in an area. The exact number of recognized specialties depends on one's purpose in counting them. The following specialties are often described:
SAFE HARBOR Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. STATEMENT Some paragraphs of this press release, particularly those describing PhotoMedex' strategies, contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1993, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While PhotoMedex is working to achieve those goals and strategies, actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, including difficulties in marketing its products and services, need for capital, competition from other companies and other factors, any of which could have an adverse effect on the business plans of PhotoMedex, its reputation in the industry or its expected financial return from operations. Factors such as these could have an adverse effect on PhotoMedex' results of operations. In light of significant uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by PhotoMedex and its subsidiaries that they will achieve such forward-looking statements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion